Bison Wealth’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7,823
Closed -$1M 459
2024
Q2
$1M Hold
7,823
0.16% 141
2024
Q1
$1M Buy
7,823
+252
+3% +$30K 0.16% 141
2023
Q4
$783K Buy
7,571
+1,613
+27% +$160K 0.14% 162
2023
Q3
$542K Buy
5,958
+172
+3% +$15.2K 0.11% 202
2023
Q2
$468K Buy
5,786
+898
+18% +$73.4K 0.09% 228
2023
Q1
$413K Sell
4,888
-106
-2% -$7.52K 0.13% 173
2022
Q4
$347K Hold
4,994
0.11% 194
2022
Q3
$248K Buy
4,994
+44
+0.9% +$2.36K 0.1% 213
2022
Q2
$276K Hold
4,950
0.16% 148
2022
Q1
$275K Hold
4,950
0.14% 171
2021
Q4
$277K Sell
4,950
-112
-2% -$6.07K 0.16% 146
2021
Q3
$243K Hold
5,062
0.11% 210
2021
Q2
$212K Sell
5,062
-1,240
-20% -$48.1K 0.09% 228
2021
Q1
$212K Hold
6,302
0.09% 230
2020
Q4
$220K Hold
6,302
0.1% 210
2020
Q3
$219K Hold
6,302
0.13% 167
2020
Q2
$206K Buy
+6,302
New +$201K 0.13% 178
2018
Q1
Sell
-7,584
Closed -$204K 210
2017
Q4
$204K Buy
+7,584
New +$193K 0.15% 193

Other funds holding NVO

Bison Wealth's NVO Position: Q3 2024 in Review

Bison Wealth sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 7,823 shares — an estimated $1M sold.

Bison Wealth first reported a position in NVO in Q4 2017 and held it in 18 quarters. The position peaked at $1M in Q2 2024. 1,785 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • Bison Wealth reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
  • Bison Wealth sold 7,823 Novo Nordisk shares in Q3 2024, an estimated $1M.
  • Bison Wealth first reported a position in Novo Nordisk in Q4 2017 and held it in 18 quarters.
  • Bison Wealth's Novo Nordisk position peaked at $1M in Q2 2024.
  • 1,785 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Bison Wealth's 13F filing for Q3 2024, filed 5 Nov 2024.